BIOX Q4 EPS Lowered by Brookline Capital Management

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Equities researchers at Brookline Capital Management cut their Q4 2025 earnings estimates for shares of Bioceres Crop Solutions in a research note issued to investors on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings per share of $0.09 for the quarter, down from their prior estimate of $0.13. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is $0.31 per share.

Several other brokerages have also commented on BIOX. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a "strong-buy" rating in a research report on Friday, July 19th. Oppenheimer cut their target price on Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating on the stock in a research report on Monday, October 21st. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a research report on Wednesday. Roth Mkm cut their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating on the stock in a report on Wednesday, September 11th. Finally, Lake Street Capital decreased their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, September 11th. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Bioceres Crop Solutions has a consensus rating of "Buy" and an average target price of $12.13.

Bioceres Crop Solutions Stock Down 6.1 %

NASDAQ:BIOX traded down $0.42 during mid-day trading on Thursday, hitting $6.42. 248,285 shares of the company's stock traded hands, compared to its average volume of 89,476. The company has a fifty day moving average of $7.66 and a 200 day moving average of $9.83. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.86 and a current ratio of 1.24. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company has a market capitalization of $403.50 million, a P/E ratio of 330.67 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter last year, the business earned ($0.07) earnings per share.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds have recently modified their holdings of the stock. Fourth Sail Capital LP lifted its stake in shares of Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after purchasing an additional 1,209,277 shares during the period. Long Focus Capital Management LLC boosted its stake in shares of Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock worth $3,145,000 after acquiring an additional 46,647 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Bioceres Crop Solutions by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after acquiring an additional 5,341 shares during the period. Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions during the 2nd quarter valued at about $448,000. Finally, Oak Family Advisors LLC increased its stake in shares of Bioceres Crop Solutions by 1.9% in the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company's stock valued at $728,000 after purchasing an additional 1,208 shares in the last quarter. Hedge funds and other institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.